CIAM
NAGE

Caitong International Asset Management’s Niagen Bioscience NAGE Stock Holding History

Caitong International Asset Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Buy
5,049
+4,741
+1,539% +$19.2K ﹤0.01% 1040
2026
Q1 		$1.36K Buy
308
+290
+1,611% +$1.57K ﹤0.01% 1341
2025
Q4 		$114 Buy
+18
New +$125 ﹤0.01% 1686
2025
Q2 		– Sell
-1,004
Closed -$6.93K – 2592
2025
Q1 		$6.93K Buy
+1,004
New +$6.31K 0.01% 945

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Caitong International Asset Management's NAGE Position: Q2 2026 in Review

Caitong International Asset Management increased its Niagen Bioscience (NAGE) stake by 1,539% in Q2 2026, buying an estimated $19.2K and bringing the position to 5,049 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1040.

Caitong International Asset Management first reported a position in NAGE in Q1 2025 and has held it in 4 quarters since. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Caitong International Asset Management held 5,049 shares of Niagen Bioscience worth $16.1K as of Q2 2026.
  • Caitong International Asset Management bought 4,741 Niagen Bioscience shares in Q2 2026, an estimated $19.2K.
  • Niagen Bioscience made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1040 holding.
  • Caitong International Asset Management first reported a position in Niagen Bioscience in Q1 2025 and has held it in 4 quarters since.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.